HomeBelgiumVIVES IUF Fund Secures €70M Equity to Catalyze Science into Startups

VIVES IUF Fund Secures €70M Equity to Catalyze Science into Startups

VIVES, a Louvain-la-Neuve, Belgium-based high-tech early-stage firm, raised €38M ($41.3M) in the second closing of VIVES IUF, bringing total funding to €70M ($76M).

The European Investment Fund (EIF), a current shareholder in VIVES I (€15M – $16.3M) and VIVES II (€42M – $45.7M), committed €25M ($27.2M), alongside current and new blue-chip investors.
This additional funding capacity of €38M will enable VIVES IUF to create ten science-based ventures and to provide additional funding support to its current portfolio of ten companies.

With these new resources, VIVES IUF can invest up to €7M ($7.6M) per portfolio company, ranging from pre-seed to Series B, focusing on sectors such as human health (incl. medtech and nutrition), agtech and engineering (incl. aerospace).

The vehicle is primarily active in Belgium and neighboring countries. As a cross-border fund, the fund has partnerships with five top-ranking European universities: UCLouvain (BE), KULeuven (BE), Université de Paris (FR), Wageningen Universiteit (NL) and Université du Luxembourg (LU). Aside from the academic deal flow, VIVES IUF also has access to a high-tech startup pipeline.

VIVES IUF plays a pivotal role in connecting academic research and innovative projects with public and private investors. Addressing the seed funding gap, VIVES IUF serves as a catalyst for transforming academic research and startups into viable, high-impact ventures. Notably, VIVES II portfolio companies raised approximately €1.5 billion ($1.6bn) in financing, demonstrating VIVES ability to transform early-stage companies from pre-seed funding into series A/B and IPOs/Trade Sales.

Led by Philippe Durieux, CEO, VIVES is a seed capital firm initiated by UCLouvain, which invests in companies developing disruptive innovations with a positive societal impact.